Helicos BioSciences Corporation Sustainability Profile
Helicos BioSciences Corporation, a pioneering entity in the biotechnology sector, is headquartered in the United States. Founded in 2006, the company has made significant strides in the field of genomics, particularly with its innovative single-molecule sequencing technology. This unique approach allows for high-throughput, accurate DNA sequencing, setting Helicos apart from traditional methods. With a focus on research and development, Helicos BioSciences serves a diverse clientele, including academic institutions and pharmaceutical companies, primarily in North America and Europe. The company has achieved notable milestones, including the launch of its Helicos Genetic Analysis System, which has garnered attention for its ability to deliver rapid and precise genomic data. As a leader in the sequencing industry, Helicos continues to push the boundaries of genetic research, contributing to advancements in personalised medicine and genomics.
DitchCarbon Score
How does Helicos BioSciences Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Helicos BioSciences Corporation's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Helicos BioSciences Corporation's reported carbon emissions
Helicos BioSciences Corporation, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Helicos BioSciences may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As such, the company appears to be operating without a defined strategy for addressing climate change or measuring its environmental impact.
How Carbon Intensive is Helicos BioSciences Corporation's Industry?
How Carbon Intensive is Helicos BioSciences Corporation's Location?
Helicos BioSciences Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Helicos BioSciences Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
